Aspen Aerogels reported Q3 2026 revenue of $85.2 million and a net loss of $10.419 million. The company appointed Stacy D. Nieuwoudt to its board. Earnings call transcripts for Q3 2026 provide detailed operational insights.

• Aspen Aerogels reported third quarter 2026 revenue of $85.2 million [N2].
• The company appointed Stacy D. Nieuwoudt to its board during Q3 2026 [N2].
• Aspen Aerogels reported a net loss of $10.419 million for the quarter ended September 30, 2026 [S2].
• The company held a Q3 2026 earnings call providing operational and financial details [N1].

The company demonstrates operational transparency through regular SEC filings and earnings calls, with revenue reaching $85.2 million in Q3 2026. Its liquidity position supports ongoing investments and operations. The appointment of new board members suggests active governance and strategic oversight.

Aspen Aerogels reported a net loss of $10.419 million in Q3 2026, indicating ongoing profitability challenges. The company operates in competitive industrial markets where technology adoption and customer concentration risks exist. Maintaining profitability and managing operational costs remain key challenges.

Aspen Aerogels' moat is based on its proprietary aerogel technology and its applications in energy efficiency and industrial insulation markets. The company's specialized materials and technology provide differentiation in thermal barrier solutions, supported by ongoing research and development investments and intellectual property protections as indicated in SEC filings.

• Profitability Risk: The company reported a net loss in the latest quarter, indicating challenges in achieving sustained profitability.
• Customer Concentration Risk: SEC filings reference customer concentration risks, which could impact revenue stability if key customers reduce orders.
• Market and Competitive Risk: Operating in specialized industrial materials markets exposes the company to competition and market demand fluctuations.

• Aspen Aerogels Inc is a company that files regular SEC reports including 10-K/A and 10-Q filings, with the latest quarterly filing dated 2026-11-05 covering the period ending 2026-09-30 [S2].
• As of September 30, 2026, Aspen Aerogels reported cash and cash equivalents of $145.991 million and current assets of $256.57 million, with current liabilities of $121.902 million, resulting in a current ratio of 2.1 and a cash ratio of 1.22 [S2].
• The company reported a net loss of $10.419 million for the quarter ending September 30, 2026, with basic and diluted earnings per share of -$0.13 [S2].
• Aspen Aerogels reported third quarter 2026 revenue of $85.2 million [N2].
• The company appointed Stacy D. Nieuwoudt to its board in the third quarter of 2026 [N2].
• Aspen Aerogels held earnings calls for Q1, Q2, and Q3 2026, providing detailed operational and financial updates [N1, N5, N8].
• The company’s business segments include energy and industrial applications, with references to thermal barrier products and international operations in SEC filings [S1, S2].
• Aspen Aerogels has a revolving credit facility and mid-cap loan facilities as part of its capital structure [S1, S2].
• The company’s recent news coverage includes multiple earnings call transcripts and revenue reports from primary financial news sources such as Nasdaq [N1, N2, N3].